MLAB · Mesa Laboratories Inc /Co/
$130.96
+5.49 (+4.38%)
At close · Sep 2
View the 10-K filed Jun 3, 2026
Customer concentration
— top customer 20% of revenue
One customer — 20% of revenue (fiscal 2026)
“In our Clinical Genomics division, a significant portion of revenues is generated from ongoing purchases by a relatively small number of established customers, with a single customer accounting for approximately 20% of the division's revenues in fiscal 2026.”
Market Cap
$702.11M
Shares
5.60M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-04 | 12 | $104.43 | $1,253 |
| 2026-08-03 | 140 | $100.81 | $14,113 |
| 2026-07-31 | 216 | $101.04 | $21,825 |
| 2026-07-29 | 898 | $101.10 | $90,788 |
| 2026-07-08 | 91 | $96.16 | $8,751 |
| 2026-07-02 | 22 | $104.39 | $2,297 |
| 2026-06-17 | 116 | $99.68 | $11,563 |
| 2026-06-03 | 70 | $106.66 | $7,466 |
Showing 1–8 of 8 settlements